Stella Priyanka S
Senior research Scientist, in vitro pharmacology with 10 years of CRO industrial experience in the area of immune-oncology drug discovery, assay development, MOA and HTS screening services. Biotechnology.
Elasmogen Ltd is a next generation therapeutic biologics company discovering and developing soloMERs™ for the treatment of auto-immune mediated, inflammatory diseases. Utilising its unique soloMER™ platform, Elasmogen exploits the power of biologics as drugs but in small, simple, and stable formats that are amenable to site-specific delivery.
